Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Enrollment status now shows no recruitment. The page adds new user guidance sections and standardizes labeling, accompanied by a site version update.
    Difference
    0.4%
    Check dated 2026-06-13T17:35:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a subsequent editorial/technical update to the record without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-06-06T13:40:49.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Adds ovarian cancer as a condition tag and introduces related topics including MedlinePlus Genetics to the study page, improving discoverability and linking to background resources.
    Difference
    0.2%
    Check dated 2026-05-30T12:03:55.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Ovarian cancer and the related topics: MedlinePlus Genetics have been removed from the page, reducing explicit disease tagging and related topics navigation.
    Difference
    0.2%
    Check dated 2026-05-23T10:22:01.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating an updated page version.
    Difference
    0.1%
    Check dated 2026-05-15T23:21:28.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s displayed revision/version from v3.5.2 to v3.5.3, without any accompanying change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:52:36.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.